| Ms Donna Michelle Pulliam, FNP-BC | |
|
600 Jefferson St Ste 600, Lafayette, LA 70501-6987 | |
| (337) 202-0720 | |
| Not Available |
| Full Name | Ms Donna Michelle Pulliam |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 600 Jefferson St Ste 600, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013389824 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
› Verified 5 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
› Verified 5 days ago
| Entity Name | Hulin Urgent Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699049262 PECOS PAC ID: 6800051285 Enrollment ID: O20120710000537 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
› Verified 5 days ago
| Entity Name | Ascension Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699118505 PECOS PAC ID: 9739320029 Enrollment ID: O20130730000082 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Donna Michelle Pulliam, FNP-BC 600 Jefferson St Ste 600, Lafayette, LA 70501-6987 Ph: (337) 202-0720 | Ms Donna Michelle Pulliam, FNP-BC 600 Jefferson St Ste 600, Lafayette, LA 70501-6987 Ph: (337) 202-0720 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
› Verified 5 days ago
Lezette G. Vienne, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2390 W Congress St, Lafayette, LA 70506 Phone: 337-261-6000 | |
Mandy Gayle Keown, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 La Rue France, 201, Lafayette, LA 70508 Phone: 337-235-9355 | |
Michael Stephen Robichaux, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 443 Heymann Blvd Ste B, Lafayette, LA 70503 Phone: 337-289-8429 Fax: 337-289-8431 | |
Mrs. Brandi Rene Boutte, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1101 Kaliste Saloom Rd Ste 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-769-0031 | |
Quartivia Gibson, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 202 General Gardner Ave, Lafayette, LA 70501 Phone: 337-232-9457 | |
Mrs. Jamila Anderson, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-289-7991 | |
Marshall Quinn Coco, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2730 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-988-1585 Fax: 337-988-1586 |